R S Birjmohun

Summary

Affiliation: Academic Medical Center
Country: The Netherlands

Publications

  1. ncbi Increasing HDL cholesterol with extended-release nicotinic acid: from promise to practice
    R S Birjmohun
    Department of Vascular Medicine, Academic Medical Centre, PO Box 22660, 1100 DD Amsterdam, The Netherlands
    Neth J Med 62:229-34. 2004
  2. ncbi Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedema
    Rakesh S Birjmohun
    Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
    Clin Ther 30:2314-23. 2008
  3. ncbi Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study
    Rakesh S Birjmohun
    Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
    PLoS ONE 4:e6809. 2009
  4. ncbi [The role of the high-density lipoprotein (HDL) particle in atherogenesis and potential methods to increase HDL concentrations]
    R S Birjmohun
    Academisch Medisch Centrum Universiteit van Amsterdam, afd Vasculaire Geneeskunde, Meibergdreef 9, 1105, AZ Amsterdam
    Ned Tijdschr Geneeskd 150:2245-50. 2006
  5. ncbi Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials
    Rakesh S Birjmohun
    Department of Vascular Medicine, Academic Medical Center of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    J Am Coll Cardiol 45:185-97. 2005
  6. ncbi Safety and tolerability of prolonged-release nicotinic acid in statin-treated patients
    R S Birjmohun
    Academic Medical Center, Amsterdam, The Netherlands
    Curr Med Res Opin 23:1707-13. 2007
  7. ncbi ApoAI-phosphatidylcholine infusion neutralizes the atherothrombotic effects of C-reactive protein in humans
    S I van Leuven
    Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    J Thromb Haemost 7:347-54. 2009
  8. ncbi Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model
    Cornelis van 't Veer
    Center for Infection and Immunity Amsterdam, The Netherland
    J Immunol 179:7110-20. 2007
  9. ncbi Loss of heterozygosity and immunohistochemistry of adenocarcinomas of the esophagus and gastric cardia
    Willem A Marsman
    Department of Experimental Hepatology, Academic Medical Center, Amsterdam, The Netherlands
    Clin Cancer Res 10:8479-85. 2004
  10. ncbi High-density lipoprotein attenuates inflammation and coagulation response on endotoxin challenge in humans
    Rakesh S Birjmohun
    Academic Medical Center of Amsterdam, Department of Vascular Medicine, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    Arterioscler Thromb Vasc Biol 27:1153-8. 2007

Collaborators

Detail Information

Publications10

  1. ncbi Increasing HDL cholesterol with extended-release nicotinic acid: from promise to practice
    R S Birjmohun
    Department of Vascular Medicine, Academic Medical Centre, PO Box 22660, 1100 DD Amsterdam, The Netherlands
    Neth J Med 62:229-34. 2004
    ..The inverse relation between high-density lipoprotein cholesterol (HDL-C) and cardiovascular (CV) disease underscores the need for clinical evaluation of the effect of HDL-C increasing drugs on the prevalence of CV disease...
  2. ncbi Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedema
    Rakesh S Birjmohun
    Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
    Clin Ther 30:2314-23. 2008
    ..However, danazol has been reported to decrease high-density lipoprotein cholesterol (HDL-C) levels and to adversely affect coagulation parameters, which are considered to be proatherothrombotic...
  3. ncbi Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study
    Rakesh S Birjmohun
    Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
    PLoS ONE 4:e6809. 2009
    ..In order to evaluate the atheroprotective potential of PON1, we assessed the relationships among PON1-genotype, PON1-activity and risk of future coronary artery disease (CAD), in a large prospective case-control study...
  4. ncbi [The role of the high-density lipoprotein (HDL) particle in atherogenesis and potential methods to increase HDL concentrations]
    R S Birjmohun
    Academisch Medisch Centrum Universiteit van Amsterdam, afd Vasculaire Geneeskunde, Meibergdreef 9, 1105, AZ Amsterdam
    Ned Tijdschr Geneeskd 150:2245-50. 2006
    ..Among these drugs are apolipoprotein A-1 variants, inhibitors of the cholesterol ester transfer protein JTT-705 and torcetrapib...
  5. ncbi Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials
    Rakesh S Birjmohun
    Department of Vascular Medicine, Academic Medical Center of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    J Am Coll Cardiol 45:185-97. 2005
    ..The aim of this research was to estimate the efficacy and safety of current high-density lipoprotein cholesterol (HDL-C)-increasing drugs...
  6. ncbi Safety and tolerability of prolonged-release nicotinic acid in statin-treated patients
    R S Birjmohun
    Academic Medical Center, Amsterdam, The Netherlands
    Curr Med Res Opin 23:1707-13. 2007
    ..To evaluate the safety and tolerability of prolonged-release nicotinic acid (Niaspan) added to statin therapy in patients at increased cardiovascular risk...
  7. ncbi ApoAI-phosphatidylcholine infusion neutralizes the atherothrombotic effects of C-reactive protein in humans
    S I van Leuven
    Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    J Thromb Haemost 7:347-54. 2009
    ..High-density lipoprotein (HDL) exerts a variety of anti-atherothrombotic functions, including a potent anti-inflammatory impact. In line, the direct pro-inflammatory effects of C-reactive protein (CRP) can be attenuated by HDL in vitro...
  8. ncbi Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model
    Cornelis van 't Veer
    Center for Infection and Immunity Amsterdam, The Netherland
    J Immunol 179:7110-20. 2007
    ..In conclusion, LPS tolerance in human endotoxemia models is associated with IRAK-M up-regulation...
  9. ncbi Loss of heterozygosity and immunohistochemistry of adenocarcinomas of the esophagus and gastric cardia
    Willem A Marsman
    Department of Experimental Hepatology, Academic Medical Center, Amsterdam, The Netherlands
    Clin Cancer Res 10:8479-85. 2004
    ..In the present study, we investigated several genetic and immunohistochemical features of adenocarcinomas of the distal esophagus and gastric cardia...
  10. ncbi High-density lipoprotein attenuates inflammation and coagulation response on endotoxin challenge in humans
    Rakesh S Birjmohun
    Academic Medical Center of Amsterdam, Department of Vascular Medicine, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    Arterioscler Thromb Vasc Biol 27:1153-8. 2007
    ..In the present study, we evaluated whether there is a relation between HDL and sensitivity toward a low-dose endotoxin challenge...